Wu, Suhui – Trademark Portfolio

Entity Type: 01

Wu, Suhui holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include SXLIFU and LOTLOVE. The owner is based in Shijiazhuang, Hebei.

Wangpo Township, Pingshan County

No. 9 Hongfu Temple, Lengquan Village

Shijiazhuang, Hebei 050400 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SXLIFU
SXLIFU
Registered 2025
LOTLOVE
LOTLOVE
Registered 2025
LOTLOVE
LOTLOVE
Registered 2025

Trademark Classifications

Wu, Suhui's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Wu, Suhui have?

Wu, Suhui has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Wu, Suhui file in?

Wu, Suhui files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 3 (Cosmetics & Cleaning). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Wu, Suhui's most well-known trademarks?

Wu, Suhui's registered trademark portfolio includes well-known marks such as SXLIFU and LOTLOVE. These are among 3 currently registered trademarks in the portfolio.

What is Wu, Suhui's trademark registration success rate?

Wu, Suhui has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.